Intra-Cellular Therapies Inc (DELISTED) (ITCI:DL)
131.87
0.00 (0.00%)
USD |
NASDAQ |
Apr 04, 16:00
Intra-Cellular Therapies Enterprise Value: 13.02B for April 4, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Johnson & Johnson | 524.44B |
| Moderna, Inc. | 9.436B |
| Eli Lilly & Co. | 991.61B |
| AbbVie, Inc. | 463.99B |
| Sage Therapeutics Inc (DELISTED) | 179.37M |
Enterprise Value Related Metrics
| Gross Profit Margin (Quarterly) | 89.76% |
| Profit Margin (Quarterly) | -8.48% |
| Earnings Yield | -0.55% |
| Normalized Earnings Yield | -0.5536 |